Bitcoin price today: dips below $112k, near 6-wk low despite Fed cut bets
Klotho Neurosciences, Inc., a micro-cap company with a market value of $6.16 million, has announced a definitive agreement to acquire SB Security Holdings, LLC, a subsidiary of SkyBell Technologies, Inc., in a major expansion move. The transaction, dated March 26, 2025, involves Klotho issuing new shares representing 90% of its post-deal common stock to SkyBell as consideration for the acquisition. The announcement comes as Klotho’s stock has declined over 98% in the past year, according to InvestingPro data.
The deal hinges on several conditions, including mutual agreement on the transaction structure, approval from Klotho’s shareholders, and Nasdaq clearance. Other prerequisites include consent from secured creditors, satisfactory due diligence outcomes, and the effectiveness of a Form S-4 Registration Statement. The parties aim to conclude the acquisition by August 13, 2025. InvestingPro analysis reveals concerning financial metrics, with a current ratio of 0.16 indicating potential liquidity challenges. Get access to 10+ additional ProTips and comprehensive financial analysis with an InvestingPro subscription.
SB Security Holdings, LLC, operating under SkyBell, offers internet-connected video doorbell services, marking Klotho’s entry into the home security market. The strategic move will significantly alter Klotho’s business profile, previously known for its focus on biological products in the life sciences sector.
The Share Exchange Agreement (SEA) outlines the terms, with Klotho set to become the majority owner of the video doorbell service company. The SEA’s full details, including certain annexes and exhibits, were not disclosed but can be provided upon request to the SEC.
Klotho Neurosciences, originally named ANEW Medical (TASE:BLWV), Inc., and later Redwoods Acquisition Corp., has undergone previous transformations, as indicated by its name changes in 2024 and 2022 respectively.
This report is based on information contained in a press release statement filed with the SEC. It reflects a significant shift in Klotho’s business strategy, as the company diversifies its portfolio by entering the home security market with this acquisition. Notably, the stock has shown counter-market behavior with a beta of -0.17, suggesting potential diversification benefits for investors. InvestingPro subscribers can access detailed valuation metrics and comprehensive financial health scores to better evaluate this strategic transformation.
In other recent news, Klotho Neurosciences, Inc. is facing potential delisting from The Nasdaq Global Markets after failing to meet minimum market value requirements. The company was notified of its non-compliance in August 2024 and given a deadline to rectify the situation by February 2025. Despite the grace period, Klotho Neurosciences did not meet the necessary standards, resulting in a Delisting Notice. The company has appealed this decision, temporarily postponing the delisting process. Additionally, Klotho Neurosciences has secured $2 million through convertible promissory notes and warrants as part of a securities purchase agreement with an institutional investor. The agreement includes two senior convertible promissory notes and warrants for up to 4 million shares of common stock. The notes, which have a 7% annual interest rate, are set to mature one year from issuance. The company plans to seek shareholder approval to authorize share issuances beyond a 19.99% threshold, with a registration statement to be filed with the SEC for the underlying shares.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.